Clinical Trials on Vaccinia

Total 1002 results

Hospital San Carlos, Madrid
Merck Sharp & Dohme LLC

Unknown

Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN. (VENUS)

HPV Infection | HPV Vaccine | Cervix Lesion | Cervix, Dysplasia

Spain
Jiangsu Province Centers for Disease Control and...

Completed

Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in Chinese

Vaccine
Jiangsu Province Centers for Disease Control and...

Completed

Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)

Safety of the Oral O1 / O139 Cholera Vaccine (Enteric Capsules)
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects

Prepandemic Influenza Vaccine

Hungary
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

Seasonal Influenza, Vaccine

Germany
Novartis Vaccines

Completed

Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Seasonal Influenza | Vaccine

Germany
University of Warwick

Completed

Influenza 2020/2021

Influenza Vaccine

United Kingdom
PATH
Institute of Experimental Medicine, Russia; Research Institute of Influenza...

Completed

Immunogenicity of H5N1 Vaccine Following H5N2

Influenza Vaccine

Russian Federation
Green Cross Corporation

Unknown

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age

Influenza Vaccine

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...
Hangzhou Medical Biotechnology Co., Ltd; CyTIX.Inc

Recruiting

Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.

Glioma | Neoplasms | Glioblastoma | Neoplasms, Neuroepithelial | Neuroectodermal Tumors | Neoplasms, Nerve Tissue | Vaccines | Immunologic Factors

China
Neuroganics LLC
Ramos Injury Law Firm

Recruiting

National Vaccine Adverse Event Reporting Survey and Etiology (NVAERS)

COVID-19 | Vaccine Adverse Reaction | Vaccine Reaction | Vasculitis | Neuritis | Thrombocytopenia | Influenza | Corona Virus Infection | Blood Clot | Guillain-Barré | Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use | GWAS | Genetic Sequencing

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules

HIV Infections | HIV Seronegativity

United States
AB Biotics, SA

Completed

Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination (FLUVAC21)

Influenza Vaccine

Spain
Beijing Center for Disease Control and Prevention

Completed

The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use

Anti-D Antibodies | Rabies Vaccine Allergy | Vaccination Adverse Event

China
University of Alberta

Completed

Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Solid Organ Transplant Recipients

Influenza Vaccine

Canada
Medical University of Vienna

Completed

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Vaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization Treatment

Austria
GlaxoSmithKline

Completed

Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age

Influenza | Influenza Vaccines

United States, Thailand, Canada
GlaxoSmithKline

Terminated

This Study Will Describe the Burden of DENgue Fever Virus (DENV) Illness Among Household Members Aged 6 Months to 50 Years of Selected Communities in Latin America and Southeast Asia

Dengue | Dengue Vaccines

Philippines, Mexico
GlaxoSmithKline

Completed

Safety and Tolerability Study of GlaxoSmithKline (GSK)1557484A Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

Influenza | Influenza Vaccines

United States
Beijing Chaoyang District Centre for Disease Control...

Completed

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

Quadrivalent Influenza Virus Vaccine

China
University of Alberta
University of Lausanne Hospitals

Completed

Intradermal Versus Intramuscular Trivalent Influenza Vaccine in Adult Lung Transplant Recipients

Influenza Vaccine | Influenza Virus

Switzerland, Canada
Northwell Health
United States Department of Defense; New York State Department of Health

Recruiting

SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI (SCIVAX)

Spinal Cord Injuries | COVID-19 Vaccine | Traumatic Spinal Cord Injury | Healthy Controls | Flu Vaccine

United States
The Immunobiological Technology Institute (Bio-Manguinhos)...

Not yet recruiting

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Measles Vaccine
GlaxoSmithKline

Completed

This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama

Hepatitis A Vaccine

Panama
Johns Hopkins Bloomberg School of Public Health

Completed

Early Immune Responses to Inactivated Influenza Vaccine: a Pilot Study

Influenza Virus Vaccine

United States
King's College London

Completed

Factors Associated With Parental Observation of Side Effects Following the Child Flu Vaccine

Influenza Vaccine, Influenza

United Kingdom
NYU Langone Health
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding Poor Vaccine Responses to Hepatitis B Vaccination

Vaccine Reaction

United States
Imperial College Healthcare NHS Trust

Completed

Nasal and Systemic Immune Responses to Nasal Influenza Vaccine (Flu-M3)

Influenza | Vaccine Virus Shedding

United Kingdom
Aga Khan University
Massachusetts General Hospital; Washington University School of Medicine; Bill... and other collaborators

Completed

Study of Environmental Enteropathy and Malnutrition in Pakistan (SEEM)

Stunting | Gastrointestinal Disease | Enteropathy | Malnutrition, Child | Vaccine Response Impaired

Pakistan
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008

Seasonal Influenza Vaccine

Germany
Seattle Children's Hospital
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age (GRC28)

Inactivated Influenza Vaccine

United States
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

Seasonal Influenza | Vaccine

Germany
Bursa Yüksek İhtisas Education and Research Hospital

Completed

Evaluation of Deltoid Exercises on Injection Site Pain After (BNT162b2) COVID - 19 Vaccination

Injection Site Reaction | Vaccines, Adverse Effects

Turkey
University of California, Davis

Completed

The Effect of Milk Components on the Response to the Pneumonia Vaccine in Senior Citizens

The Effect of Milk Components on the Response to Pneumococcal Vaccines in the Elderly
Vaxart

Completed

Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults

Seasonal Influenza Preventative Vaccine Pharmacodynamics

United States
University of Lausanne Hospitals

Completed

Imiquimod and Influenza Vaccine for Immunocompromised Patients (IMIFLU)

Influenza Vaccine

Switzerland
University of California, Los Angeles

Recruiting

Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up

COVID-19 | Vaccines

United States
Cellid Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

COVID-19 | Vaccines

Korea, Republic of
Chiang Mai University
Faculty of Medicine, Chiang Mai University

Not yet recruiting

Immunogenicity and Safety of Inactivated and Live-attenuated HAV Vaccine Among Thai Healthy Children and Adolescents (HAV-RCT)

Hepatitis A | Vaccine-Preventable Diseases | Hep A | HAV
Public Health England
Institute of Child Health

Completed

A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™). (LAIV Immuno)

Live Attenuated Influenza Vaccine

United Kingdom
Novartis Vaccines

Completed

Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules

Pre-pandemic Influenza Vaccine

Czech Republic
Beijing Chaoyang District Centre for Disease Control...

Unknown

Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

Quadrivalent Influenza Virus Vaccine
Emory University
National Institute of Nursing Research (NINR)

Recruiting

Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study (CHAMPS)

Human Papilloma Virus | Human Papilloma Virus Vaccine

United States
Vanderbilt University
Centers for Disease Control and Prevention

Completed

Cell Mediated Immunity in Older Adults (CMI)

Immunity to Influenza Vaccine

United States
Chisquares Incorporated

Not yet recruiting

Collaborative Open Research Initiative Study (CORIS-1) (CORIS-1)

COVID-19 | Burnout, Professional | Patient Engagement | Artificial Intelligence | Substance Use Disorders | Mental Health Issue | Climate Change | Preventable Disease, Vaccine | Emerging Infectious Disease | Online Education
Jomo Kenyatta University of Agriculture and Technology

Completed

Iron and COVID-19 Vaccine Response

Iron Deficiency Anemia | COVID-19 Vaccine | Iron Deficiency Anemia Treatment | Vaccine Response Impaired

Kenya
Mahidol University

Not yet recruiting

Dengue Vaccine Hesitancy Among International Travelers

Vaccine Hesitancy
Medical Corps, Israel Defense Force

Unknown

Assessment of HBV Vaccine Immunity After 18 Years

Hepatitis b Vaccine

Israel
Pontificia Universidad Catolica de Chile
Sinovac Biotech Co., Ltd; Ministry of Health, Chile

Active, not recruiting

Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults (CoronaVac3CL)

Covid19 | Vaccines

Chile
USDA, Western Human Nutrition Research Center
University of Minnesota

Recruiting

WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study

Inflammation | Typhoid Fever | Vaccine | Intestinal Permeability

United States

Clinical Trials on Vaccinia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations